Figure 4*. Effect of isoflurane on the total vasorelaxation response (filled bars) to bradykinin (A) or A23187 (B), and on the prostacyclin-mediated component (open bars) and the nitric oxide-mediated component (lined bars) of relaxation induced by these agonists. The nitric oxide-mediated and prostacyclin-mediated components of relaxation were calculated from areas above the agonist concentration-effect curves after inhibition with indomethacin and Nomega-nitro-L-arginine methyl ester, respectively (summarized in Figure 3and Figure 5). These areas are expressed as a percentage of the total vasorelaxation response (n = 5). Isoflurane attenuated (*P < 0.05) the total vasorelaxation response to both bradykinin and A23187 but had no effect on the individual vasorelaxant components mediated by either prostacyclin or nitric oxide.

Figure 4*. Effect of isoflurane on the total vasorelaxation response (filled bars) to bradykinin (A) or A23187 (B), and on the prostacyclin-mediated component (open bars) and the nitric oxide-mediated component (lined bars) of relaxation induced by these agonists. The nitric oxide-mediated and prostacyclin-mediated components of relaxation were calculated from areas above the agonist concentration-effect curves after inhibition with indomethacin and Nomega-nitro-L-arginine methyl ester, respectively (summarized in Figure 3and Figure 5). These areas are expressed as a percentage of the total vasorelaxation response (n = 5). Isoflurane attenuated (*P < 0.05) the total vasorelaxation response to both bradykinin and A23187 but had no effect on the individual vasorelaxant components mediated by either prostacyclin or nitric oxide.

Close Modal

or Create an Account

Close Modal
Close Modal